Understand the source comparison
Hexarelin Interactions: Compound Comparison
Somatostatin analogs (octreotide, pasireotide) Direct inhibition of somatotroph GH release via SSTR2/SSTR5 agonism 60–75% reduction in GH pulse amplitude regardless of hexarelin dose Active throughout analog's half-life (8–12 hours for octreotide) Most potent
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Somatostatin analogs (octreotide, pasireotide)
- Direct inhibition of somatotroph GH release via SSTR2/SSTR5 agonism
- 60–75% reduction in GH pulse amplitude regardless of hexarelin dose
- Active throughout analog's half-life (8–12 hours for octreotide)
- Most potent suppressor of hexarelin activity. Avoid concurrent use in GH research designs
- Insulin / Postprandial state
- Suppresses GHRH neurons and increases somatostatin release
- 40–50% reduction in GH response when administered in fed state
- Peak suppression 30–90 min post-meal; nadir 8–12 hours fasted
- Fasted-state administration is non-negotiable for reproducible hexarelin response
- GHRP-6, GHRP-2, Ipamorelin
- Competitive binding at GHS-R1a receptor
- 35–48% reduction per compound when co-administered at equimolar doses
- No synergy. Receptor competition throughout overlapping half-lives
- Concurrent GHS-R1a agonists reduce efficacy; stagger administration by 6+ hours if multi-agent design required
- Glucocorticoids (dexamethasone, prednisone)
- Suppression of GHRH signaling, upregulation of somatostatin, reduced GHS-R1a expression
- 55–68% reduction in GH pulse amplitude with chronic exposure
- Suppressive effect persists 48–72 hours post-dose
- Chronic glucocorticoid exposure creates functional ceiling on hexarelin. Consider washout period
- Thyroid hormone (T3)
- Increases somatotroph sensitivity to GHS-R1a agonism
- 30–40% enhancement in euthyroid vs hypothyroid models
- Requires steady-state T3 levels (7–10 days supplementation)
- Thyroid status is permissive variable. Euthyroid state required for maximal hexarelin response
- Testosterone / Estradiol
- Sex-specific modulation of GH pulse amplitude and frequency
- 20–35% higher GH response in presence of physiological estradiol; androgen permissive for amplitude
- Hormonal milieu must be stable for 2+ weeks
- Sex hormones modulate hexarelin ceiling. Hypogonadal models show blunted responses